Mostrar el registro sencillo

dc.contributor.authorWittebrood, Casperes_ES
dc.contributor.authorBoban, Marinaes_ES
dc.contributor.authorCagnin, Annchiaraes_ES
dc.contributor.authorCapellari, Sabinaes_ES
dc.contributor.authorDe Winter, François-Laurentes_ES
dc.contributor.authorDjamshidian, Atbines_ES
dc.contributor.authorMenéndez González, Manueles_ES
dc.contributor.authorHjermind, Lena E.es_ES
dc.contributor.authorKrajcovicova, Lenkaes_ES
dc.contributor.authorKrüger, Joahannaes_ES
dc.contributor.authorLevin, Johanneses_ES
dc.contributor.authorReetz, Kathrines_ES
dc.contributor.authorRodríguez Rodríguez, Eloy Manuel es_ES
dc.contributor.authorRohrer, Jonathanes_ES
dc.contributor.authorVan Langenhove, Times_ES
dc.contributor.authorReinhard, Carolaes_ES
dc.contributor.authorGraessner, Holmes_ES
dc.contributor.authorRusina, Robertes_ES
dc.contributor.authorSaracino, Darioes_ES
dc.contributor.authorHouot, Mariones_ES
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2025-03-05T11:58:13Z
dc.date.available2025-03-05T11:58:13Z
dc.date.issued2024es_ES
dc.identifier.issn1351-5101es_ES
dc.identifier.issn1468-1331es_ES
dc.identifier.urihttps://hdl.handle.net/10902/35877
dc.description.abstractBackground and Purpose: Frontotemporal dementia (FTD) is a neurodegenerative disorder characterized by pervasive personality and behavioural disturbances with severe impact on patients and caregivers. In current clinical practice, treatment is based on nonpharmacological and pharmacological approaches. Unfortunately, trial-based evidence supporting symptomatic pharmacological treatment for the behavioural disturbances in FTD is scarce despite the significant burden this poses on the patients and caregivers. Method: The study examined drug management decisions for several behavioural disturbances in patients with FTD by 21 experts across European expert centres affiliated with the European Reference Network for Rare Neurological Diseases (ERN-RND). Results: The study revealed the highest consensus on drug treatments for physical and verbal aggression, impulsivity and obsessive delusions. Antipsychotics (primarily quetiapine) were recommended for behaviours posing safety risks to both patients and caregivers (aggression, self-injury and self-harm) and nightly unrest. Selective serotonin reuptake inhibitors were recommended for perseverative somatic complaints, rigidity of thought, hyperphagia, loss of empathy and for impulsivity. Trazodone was specifically recommended for motor unrest, mirtazapine for nightly unrest, and bupropion and methylphenidate for apathy. Additionally, bupropion was strongly advised against in 10 out of the 14 behavioural symptoms, emphasizing a clear recommendation against its use in the majority of cases. Conclusions: The survey data can provide expert guidance that is helpful for healthcare professionals involved in the treatment of behavioural symptoms. Additionally, they offer insights that may inform prioritization and design of therapeutic studies, particularly for existing drugs targeting behavioural disturbances in FTD.es_ES
dc.description.sponsorshipThis study has been supported by ERN-RND, which is partly cofunded by the European Union within the framework of the ERNRND ERN-2022—Framework Partnership Agreement 2022–23.
dc.format.extent11 p.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceEuropean Journal of Neurology, 2024, 31, e16446es_ES
dc.subject.otherDrug therapyes_ES
dc.subject.otherExpert testimonyes_ES
dc.subject.otherFrontotemporal dementiaes_ES
dc.subject.otherNeurobehavioural manifestationses_ES
dc.subject.otherNeurodegenerative diseaseses_ES
dc.titlePharmacotherapy for behavioural manifestations in frontotemporal dementia: an expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND)es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1111/ene.16446es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1111/ene.16446es_ES
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International